Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

AGEN

Agenus (AGEN)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AGEN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>

Date	Time	Source	Headline	Symbol	Company
01/06/2021	5:43PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
01/06/2021	5:27PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
01/06/2021	5:02PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
01/05/2021	1:03PM	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:AGEN	Agenus Inc
01/04/2021	4:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
12/21/2020	2:52PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
12/21/2020	2:44PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
12/21/2020	2:34PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
12/21/2020	2:25PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
12/21/2020	2:16PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
12/21/2020	2:07PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
12/21/2020	1:42PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
12/21/2020	1:31PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
12/21/2020	1:17PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
12/21/2020	12:42PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:AGEN	Agenus Inc
12/21/2020	12:42PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
12/04/2020	5:55PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
12/03/2020	7:45AM	GlobeNewswire Inc.	Completion of Balstilimab BLA Filing Extended To 1H2021	NASDAQ:AGEN	Agenus Inc
12/01/2020	8:00AM	GlobeNewswire Inc.	Agenus Launches Phase 2 Trial Expansion in Colon Cancer for AGEN1181 in Combination with Balstilimab	NASDAQ:AGEN	Agenus Inc
11/25/2020	4:03PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGEN	Agenus Inc
11/25/2020	1:28PM	GlobeNewswire Inc.	Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference	NASDAQ:AGEN	Agenus Inc
11/16/2020	7:04PM	GlobeNewswire Inc.	Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference	NASDAQ:AGEN	Agenus Inc
11/13/2020	2:42PM	GlobeNewswire Inc.	Agenus and Dr. Steven O’Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data	NASDAQ:AGEN	Agenus Inc
11/12/2020	9:00AM	GlobeNewswire Inc.	Agenus and Dr. Steven O’Day to Participate in Panels at the Virtual SITC 2020 Immuno-Oncology Event Hosted by B. Riley	NASDAQ:AGEN	Agenus Inc
11/11/2020	7:30AM	GlobeNewswire Inc.	XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement	NASDAQ:AGEN	Agenus Inc
11/10/2020	8:45AM	GlobeNewswire Inc.	An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2	NASDAQ:AGEN	Agenus Inc
11/09/2020	4:17PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AGEN	Agenus Inc
11/09/2020	8:15AM	GlobeNewswire Inc.	Agenus Presents Additional Clinical Responses and Novel Biomarker Data at SITC2020	NASDAQ:AGEN	Agenus Inc
11/05/2020	8:00AM	GlobeNewswire Inc.	Dr. Steven O’Day Named Agenus Chief Medical Officer	NASDAQ:AGEN	Agenus Inc
11/02/2020	8:45AM	GlobeNewswire Inc.	Agenus Doses First COVID-19 Patient with iNKT Cell Therapy	NASDAQ:AGEN	Agenus Inc